logo.png
  • Home

  • About

    • Company Overview
    • The Team
    • Partners
  • Science

    • Overview
    • Immunotherapy
    • Technology
    • Pipeline
  • News

  • Contact

  • More

    Use tab to navigate through the menu items.
    media.jpg

    News

    News

    Axis Therapeutics Announces Research Collaboration with PharmaEssentia for Development of TCR-T Cell Therapy in Taiwan

    13 October 2020

    Athenex Announces FDA Allowance of IND Application for TCRT-ESO-A2, a TCR-T Cell Therapy

    23 September 2020

    Athenex Announces Appointment of Daniel Lang MD to Lead TCR-T Immunotherapy Operations and Support Corporate Development Strategy

    04 September 2019

    Athenex Announces Appointment of Dr. Daniel Von Hoff as Chairman of the Scientific Advisory Board of Axis Therapeutics Limited

    28 March 2019

    Athenex Announces Xiangxue Life Sciences Receives IND Allowance from China’s National Medical Products Administration for Cancer Immunotherapy Drug Candidate

    21 March 2019

    关于TAEST16001注射液申报临床试验获得受理的公告

    29 December 2018

    Athenex and Xiangxue Life Sciences Announce Preliminary Results of Patients Receiving T-Cell Receptor Affinity Enhancing Specific T-Cell Therapy (TAEST) Showed Encouraging Positive Clinical Signals

    15 October 2018

    Athenex Announces Pipeline Expansion Initiatives in Conjunction with a Strategic Investment of $100 million by Perceptive Advisors

    02 July 2018

    1
    2
    Back to Top

    Get in touch with us

    Contact

    Science

    News

    Contact

    logo-white.png
    Comany Overview
    The Team
    Partners

    About

    Overview
    Immunotherapy
    Technology
    Pipeline
    News
    Find Us

    © Copyright Axis Therapeutics 2020. All Rights Reserved.

    Terms & Conditions
    Privacy Policy